Sort
59,101 grants matching “hypertension”
Inverse neurovascular coupling in the hypothalamus and its role in positive feedback regulation of Vasopressin neurons in health and disease
$671,936Javier E Stern · Georgia State University · R01 · FY2023 · HL
Inverse neurovascular coupling in the hypothalamus and its role in positive feedback regulation of Vasopressin neurons in health and disease
$671,936Javier E Stern · Georgia State University · R01 · FY2025 · HL
JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease
$671,935Opeyemi Ayodeji Olabisi · Duke University · R01 · FY2022 · MD
The state of energy in the right ventricle of patients with pulmonary arterial hypertension
$671,932Arash Kheradvar · University Of California-Irvine · R01 · FY2022 · HL
Exploring the Fuel-Mediated Programming of Neonatal Growth
$671,894Dana Dabelea · University Of Colorado Denver · R01 · FY2016 · DK
Urate as a Predictor of Parkinson's Disease Risk and Progression
$671,891Alberto Ascherio · Harvard School Of Public Health · R01 · FY2011 · NS
Escalating Proportion of Weight-Loss Maintainers Via Modules Prior to Weight Loss
$671,850Michaela Kiernan · Stanford University · R01 · FY2019 · HL
Fibroblasts and Mononuclear Fibrogenic Cells Drive Right Ventricular Pulmonary Ar
$671,793Kurt R Stenmark · University Of Colorado Denver · R01 · FY2014 · HL
Advancing understanding of racism-related health disparities beginning before birth: A multisite study with Black and Latina pregnant women
$671,787Sierra E Carter · Georgia State University · R01 · FY2023 · HD
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
$671,775Bei Wu · Rutgers Biomedical And Health Sciences · P50 · FY2025 · MD
Genetics of In Vivo and In Vitro Endothelial Function in African Americans
$671,767Michael David Brown · Temple Univ Of The Commonwealth · R01 · FY2009 · HL
Cardiometabolic Risk Development and Management in Changing Neighborhoods: the Jackson Heart Study
$671,748Sharrelle M Barber · Drexel University · R01 · FY2022 · HL
Guiding next steps for SPRINT-MIND implementation: Identifying high-benefit subgroups and comparative effects of ARB- vs. ACEI-based regimens
$671,692Adam P Bress · University Of Utah · R01 · FY2021 · AG
Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension
$671,690Italo Biaggioni · Vanderbilt University Medical Center · R01 · FY2025 · HL
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
$671,674Veerle Bergink · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · MH
Patient-Physician Partnership to Improve HBP Adherence
$671,653Johns Hopkins University · R01 · FY2002 · HL
Collaborative Management of Hypertension
$671,651University Of Iowa · R01 · FY2005 · HL
In Vivo Function and Metabolism Evaluation of Glaucomatous RGCs by Two-Photon Scanning Laser Ophthalmology
$671,615Yang Hu · Stanford University · R01 · FY2024 · EY
Uric Acid and Hypertension in African-Americans
$671,612Mark S. Segal · University Of Florida · R01 · FY2008 · HL
Residential Segregation and Physiological Dysregulation among Black CARDIA participants: A Longitudinal Study
$671,600Sarah N Forrester · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · HL
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
$671,594David J Fulton · Augusta University · R01 · FY2024 · HL
Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension
$671,588Italo Biaggioni · Vanderbilt University Medical Center · R01 · FY2023 · HL
Skull marrow crosstalk with the central nervous system
$671,572Michael A Moskowitz · Massachusetts General Hospital · R01 · FY2020 · NS
Assessment of the Impact of antihypertensive Medications on vascular and renal outcomes in Chronic Kidney Disease (AIM-CKD)
$671,516Ming Wang · Case Western Reserve University · R01 · FY2024 · HL
Inflammation, long-term diabetes characteristics, and cognitive decline
$671,515Michal Schnaider Beeri · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · AG